These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8543073)

  • 1. Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
    Newman DK; Isaacs JD; Watson PG; Meyer PA; Hale G; Waldmann H
    Eye (Lond); 1995; 9 ( Pt 5)():564-9. PubMed ID: 8543073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival.
    He Y; Mellon J; Apte R; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3218-25. PubMed ID: 7913917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal graft rejection.
    Panda A; Vanathi M; Kumar A; Dash Y; Priya S
    Surv Ophthalmol; 2007; 52(4):375-96. PubMed ID: 17574064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study.
    Küchle M; Cursiefen C; Nguyen NX; Langenbucher A; Seitz B; Wenkel H; Martus P; Naumann GO
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):580-4. PubMed ID: 12136292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamellar keratoplasty in the management of inflammatory corneal ulceration and perforation.
    Bessant DA; Dart JK
    Eye (Lond); 1994; 8 ( Pt 1)():22-8. PubMed ID: 8013714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-diameter penetrating keratoplasty: indications and outcomes.
    Skeens HM; Holland EJ
    Cornea; 2010 Mar; 29(3):296-301. PubMed ID: 20118782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rejection of corneal allografts].
    Guilbert E; Laroche L; Borderie V
    J Fr Ophtalmol; 2011 May; 34(5):331-48. PubMed ID: 21492957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Corneal transplantation].
    Mellin KB
    Zentralbl Chir; 1992; 117(12):695-700. PubMed ID: 1285478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amniotic membrane graft in ocular surface disease. Prospective study with 31 cases].
    Muraine M; Descargues G; Franck O; Villeroy F; Toubeau D; Menguy E; Martin J; Brasseur G
    J Fr Ophtalmol; 2001 Oct; 24(8):798-812. PubMed ID: 11894530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of corneal allografts and xenografts to antibody-mediated rejection.
    Holán V; Vítová A; Krulová M; Zajícová A; Neuwirth A; Filipec M; Forrester JV
    Immunol Lett; 2005 Sep; 100(2):211-3. PubMed ID: 15869803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal melting in rheumatoid arthritis patients treated with a tectonic reinforcing corneolimbal graft: an interventional case series.
    Livny E; Mimouni M; Bahar I; Molad Y; Gershoni A; Kremer I
    Int Ophthalmol; 2018 Jun; 38(3):1317-1324. PubMed ID: 28432580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody.
    He YG; Ross J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2723-8. PubMed ID: 1680112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interim results from the prospective "Erlanger Non-high-risk Penetrating Keratoplasty Study" in 207 patients].
    Graupner M; Seitz B; Langenbucher A; Martus P; Blüthner K; Nguyen NX; Wenkel H; Küchle M
    Klin Monbl Augenheilkd; 2000 Sep; 217(3):163-70. PubMed ID: 11076347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal allograft rejection: risk factors, diagnosis, prevention, and treatment.
    Dua HS; Azuara-Blanco A
    Indian J Ophthalmol; 1999 Mar; 47(1):3-9. PubMed ID: 16130277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal transplant allograft reactions in unilateral, double corneal transplants.
    Rozenman J; Arentsen JJ; Laibson PR
    Cornea; 1985-1986; 4(1):25-9. PubMed ID: 3912114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.